Related Experiment Video
Updated: Jul 29, 2025
06:32
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
2.2K
Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis.
Shitao Jiang1, Yaoge Liu, Han Zheng
1Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
International Journal of Surgery (London, England)
|May 22, 2023
Summary
Neoadjuvant immunotherapy shows greater clinical benefits than adjuvant therapy for surgical cancer patients. This bibliometric analysis maps the growth and key players in neoadjuvant immunotherapy research.
Area of Science:
- Oncology
- Immunology
- Bibliometrics
Background:
- Neoadjuvant immunotherapy offers potential clinical advantages over adjuvant therapy in cancer treatment.
- Understanding the research landscape of neoadjuvant immunotherapy is crucial for future advancements.
Approach:
- A bibliometric analysis was conducted on 1222 publications from the Web of Science Core Collection up to February 12, 2023.
- VOSviewer and CiteSpace were utilized for co-authorship, keyword co-occurrence, and bursting reference analysis.
- The study mapped research trends, key contributors, and influential publications over two decades.
Key Points:
- The United States, China, and Italy are leading contributors to neoadjuvant immunotherapy research.
- Frontiers in Oncology is the most prolific journal in this field.
- Key terms include 'immunotherapy' and 'neoadjuvant therapy', with Francesco Montorsi noted for a high H-index.
Conclusions:
- This bibliometric analysis provides a comprehensive overview of the neoadjuvant immunotherapy research field.
- The findings highlight the global research activity and key influencers in neoadjuvant immunotherapy development.
Related Concept Videos
01:27Tumor Immunotherapy
584
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
584
01:30Cancer Vaccines
447
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
447
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K